Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 61.4M | 69.6M | 68.6M | 78.1M |
| Cost of revenue | 52.4M | 64.9M | 56.6M | 65.1M |
| Gross profit | 9.0M | 4.6M | 12.0M | 13.0M |
| Operating expense | ||||
| Research & development | 813K | 1.4M | 1.9M | 1.7M |
| Selling general and admin | 18.7M | 18.4M | 17.5M | 18.1M |
| Other operating expenses | — | — | — | — |
| Operating income | -10.5M | -15.3M | -7.4M | -6.9M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 3.6M | 3.9M | 3.6M | 3.0M |
| Other income expense | 11.0M | -49.6M | -10.4M | -8.2M |
| Pretax income | -3.1M | -68.8M | -21.4M | -18.1M |
| Tax provision | -182K | -1.7M | -472K | 15K |
| Net income | -2.9M | -67.2M | -21.0M | -18.1M |
| Basic EPS | -0.1 | -1.4 | -0.4 | -0.4 |
| Diluted EPS | -0.1 | -1.4 | -0.4 | -0.4 |
| Basic average shares | 71.2M | 66.8M | 66.5M | 65.7M |
| Diluted average shares | 71.2M | 66.8M | 66.5M | 65.7M |
| EBITDA | 7.3M | -58.0M | -9.8M | -11.9M |
| Net income from continuing op. | -2.9M | -67.2M | -21.0M | -18.1M |
| Minority interests | 0 | 0 | 0 | -5K |
| Preferred stock dividends | — | — | — | — |